Diabetes Care, Vol 10, Issue 6 712-715, Copyright © 1987 by American Diabetes Association
Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department
A Collier, DJ Steedman, AW Patrick, GR Nimmo, DM Matthews, CC MacIntyre, K Little and BF Clarke
Diabetic and Dietetic Department, Royal Infirmary, Edinburgh, United Kingdom.
Hypoglycemia is a serious problem in insulin-treated diabetic patients. In
this study the efficacy of intravenous glucagon (1 mg) was compared with
that of intravenous dextrose (25 g) in the treatment of hypoglycemia in
insulin-treated patients attending an accident and emergency department. In
addition, the prevailing glycemic control of these patients was compared
with patients routinely attending a diabetic outpatient clinic. Both
intravenous glucagon and dextrose were effective in the treatment of
hypoglycemic coma. There was a difference in the glycemic profile after
intravenous glucagon compared with intravenous dextrose, and recovery of a
normal level of consciousness after glucagon was slower than after dextrose
(6.5 vs. 4.0 min, respectively; P less than .001), although the average
duration of hypoglycemic coma was 1.4 h. The glucagon- and dextrose-treated
groups had significantly lower HbA1 than comparable patients routinely
attending the clinic (9.5 +/- 0.8 vs. 12.0 +/- 3.8%, respectively; P less
than .001). In view of the ease of administration and the small risk of
vascular and extravascular complications, intravenous glucagon appears to
be a useful alternative to intravenous dextrose in the treatment of severe
hypoglycemia.